Event Type
Disclosure
Mandatory
Variant
8-K
. Results of Operations and Financial Condition. On February 24, 2026, Harmony Biosciences Holdings, Inc. (the “Company”) issued a press release announcing its
. Regulation FD Disclosure. On February 24, 2026, the Company posted an investor presentation to its website at ttps://ir.harmonybiosciences.com (the “Investo
. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1* Press release issued by the Company, dated February 24,